Revvity, Inc., formerly known as PerkinElmer, Inc., is a key player in the diagnostics and life sciences markets. The company provides advanced solutions across various sectors including healthcare, agriculture, and industrial applications, offering vast opportunities for growth. However, potential regulatory challenges and market competition may pose risks.
The fundamentals of Revvity, Inc. highlight a moderate overall strength with specific emphasis on Discounted Cash Flow and Price to Book ratios.
Category | Score | |
---|---|---|
Discounted Cash Flow | 4 | |
Return on Equity | 3 | |
Return on Assets | 3 | |
Debt to Equity | 2 | |
Price to Earnings | 1 | |
Price to Book | 4 |
The historical data shows consistency in the company's performance, with stable scores across key financial metrics.
Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-07-14 | 3 | 4 | 3 | 3 | 2 | 1 | 4 |
(Previous) | 0 | 4 | 3 | 3 | 2 | 1 | 4 |
Analyst estimates are optimistic with a consensus price target that points to substantial stock growth potential.
High | Low | Median | Consensus |
---|---|---|---|
140 | 140 | 140 | 140 |
The sentiment among analysts reflects a predominantly favorable view with a majority of 'Buy' recommendations.
Recommendation | Number | |
---|---|---|
Strong Buy | 0 | |
Buy | 17 | |
Hold | 12 | |
Sell | 0 | |
Strong Sell | 0 |
Revvity, Inc. presents a solid investment opportunity with strong fundamentals and positive analyst sentiment. The company's growth potential is supported by its comprehensive product and service offerings in key sectors. However, potential investment risks include market volatility and operational challenges. Investors should consider these factors in line with their risk tolerance and market conditions before making investment decisions.